Healthcare providers play a crucial role in advancing medical research through clinical trials. However, a significant gap persists in the participation of Black women in these vital studies. A recent report titled “Layered” by GCI Health offers valuable insights into this issue and provides strategies for increasing engagement and trust among Black women in clinical trials.
Understanding the Current Landscape
Kianta Key, senior vice president and identity experience lead at GCI Health, led this important research. The study surveyed 500 Black women aged 18-80 across 38 U.S. states, revealing several key findings:
-
- Lack of Outreach: An alarming 73 percent of Black women surveyed have never been invited to participate in a clinical trial. This highlights a significant gap in our engagement efforts as healthcare providers.
- Safety Concerns: Safety emerged as a top priority for Black women considering clinical trial participation. Key notes to BDO: “I think number one is side effects. Like, this is a new drug. You know? I wanna make sure that it is not a side effect that maybe I am uncomfortable with or if you have a certain, you know, you might have a certain job.”
- Historical Context: The report acknowledges the impact of historical injustices on trust in healthcare. As providers, we must be sensitive to this context.
- Influencer Impact: For younger Black women, influencers and celebrities play a significant role in shaping perceptions about clinical trials. This suggests potential avenues for outreach and education.
Addressing Barriers to Participation
As healthcare providers, we can take several steps to increase Black women’s participation in clinical trials:
- Proactive Outreach: We must actively engage with our Black female patients about clinical trial opportunities. Key emphasizes: “We have to demand or ask for it sometimes.”
- Education and Transparency: Clear communication about safety protocols, potential side effects, and the overall process is crucial. Key advises: “I think taking the time out to explain the safety is paramount.”
- Logistical Support: Recognize and address the real-life challenges faced by potential participants. Key explains: “They make a bunch of assumptions of how, the people that will be in the trial. Right? And that’s because a lot of times the trials are not designed, for for all people.”
- Cultural Competence: Tailor communication and outreach efforts to resonate with Black women. Key suggests: “We have to start off again with the data, who’s being impacted by that condition, where they are that matters to me.”
Improving Patient-Provider Communication
Key emphasizes the importance of open dialogue in healthcare settings:
“We have to take that same audacity, that same courage into the doctor’s office and say, hey. I don’t understand this. Or, look, you’re you’re my person, and I need you to do these things for me because I want to be here for the next one hundred years. How do we get there? What is the plan? What is the road map?”
As providers, we should encourage and facilitate these conversations, creating a safe space for patients to ask questions and express concerns.
The Importance of Diversity in Clinical Trials
Increasing diversity in clinical trials is essential for improving the quality and applicability of medical research. Key explains:
“You don’t wanna have a, a trial or any experiment where the, sort of the subject in the study looks the same, sounds the same. That means that you won’t you don’t know if it works for other people.”
She adds: “Clinical trials is not just about to me, this is beyond diversity. It’s just sort of where is the need. Right? And that’s where we should really be starting.”
As healthcare providers, we have a responsibility to advocate for diverse representation in clinical trials to ensure the development of treatments that are effective for all populations.
Moving Forward
To increase Black women’s participation in clinical trials, we must:
- Actively discuss clinical trial opportunities with our Black female patients
- Provide clear, culturally competent information about the process and safety measures- Address logistical barriers that may prevent participation
- Foster trust through open communication and acknowledgment of historical contexts- Advocate for diverse representation in clinical trials at an institutional level
By implementing these strategies, we can contribute to a more inclusive and effective clinical trial landscape, ultimately improving healthcare outcomes for all patients.
Key reminds us of the potential impact: “[Black women] are powerful. We know the things. It’s in us. It’s in our DNA. It’s coded. It’s in our genes. I think that is a powerful. You have a story to tell and get Black women to participate.”
As healthcare providers, let’s commit to bridging this gap and ensuring that our Black female patients have equal opportunities to contribute to and benefit from medical research.